Skolnick Phil
- SEC CIK
- 0001358116
No open-market purchases or sales filed in the past year.
Current role at each company
- OPNT Opiant Pharmaceuticals, Inc.Chief Scientific Officeras of Mar 3, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Skolnick Phil as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 (view filing) | Jan 27 | 4 days | Skolnick PhilChief Scientific Officer | SSale | −480 | $20.26 | −$9.72K | −2.2%21.5K after | |
| Jan 9, 2023 (view filing) | Jan 9 | Same day | Skolnick PhilChief Scientific Officer | SSale | −369 | $20.20 | −$7.45K | −1.6%22.0K after | |
| Jan 5, 2023 (view filing) | Jan 5 | Same day | Skolnick PhilChief Scientific Officer | SSale | −1.42K | $20.20 | −$28.7K | −6.0%22.4K after | |
| Jul 15, 2022 (view filing) | Jul 14 | 1 day | Skolnick PhilChief Scientific Officer | SSale | −627 | $11.85 | −$7.43K | −2.6%23.8K after | |
| Jan 27, 2022 (view filing) | Jan 27 | Same day | Skolnick PhilChief Scientific Officer | SSale | −1.52K | $26.19 | −$39.8K | −6.3%22.4K after | |
| Jan 12, 2022 (view filing) | Jan 10 | 2 days | Skolnick PhilChief Scientific Officer | SSale | −385 | $30.49 | −$11.7K | −1.6%24.0K after |